EXCRETION OF BETA-N-ACETYLGLUCOSAMINIDASE IN URINE OF TYPE-I AND TYPE-II DIABETICS WITH AND WITHOUT NEPHROPATHY

被引：0
|
作者：
WERLE, E
BOSTEDT, A
FIEHN, W
HASSLACHER, C
机构：
[1] UNIV KLIN HEIDELBER,MED KLIN & POLIKLIN,ZENT LAB,HEIDELBERG,GERMANY
[2] UNIV KLIN HEIDELBERG,MED KLIN,ENDOKRINOL & STOFFWECHSEL ABT,HEIDELBERG,GERMANY
来源：
WIENER KLINISCHE WOCHENSCHRIFT | 1991年 / 103卷
关键词：
BETA-N-ACETYLGLUCOSAMINIDASE (BETA-NAG); DIABETES-MELLITUS; GLOMERULAR AND TUBULOINTERSTITIAL NEPHROPATHY;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The clinical aspects of the excretion of beta-N-acetylglucosaminidase (beta-NAG, EC3.2.1.30) in urine of type I and type 11 diabetics with and without nephropathy are evaluated. Correlation between concentration of albumin and of beta-NAG activity in urine is determined and the circadian rhythm of beta-NAG excretion in urine is examined, the indication of glomerular and tubulointerstitial damage is discussed. Longitudinal studies should demonstrate, whether an increased beta-NAG activity in urine of diabetics with normoalbuminuria is an indicator of nephropathy or a predictor of nephropathy if raised albuminuria is observed.
引用
收藏
页码：59 / 62
页数：4
相关论文
共 50 条
  • [1] ANTIPYRINE DISPOSITION IN TYPE-I AND TYPE-II DIABETICS
    ZYSSET, T
    WIETHOLZ, H
    THERAPIE, 1988, 43 (02): : 158 - 158
  • [2] ARTERIAL-HYPERTENSION IN TYPE-I AND TYPE-II DIABETES WITHOUT NEPHROPATHY
    FEKETE, T
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1984, 20 (6B): : 1483 - 1483
  • [3] CHARACTERISTICS OF PAINFUL NEUROPATHY IN TYPE-I AND TYPE-II DIABETICS
    CLEMENTS, RS
    VITTOR, VJ
    HELMS, EF
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1984, 20 (6B): : 1482 - 1482
  • [4] EARLY DIAGNOSIS OF DIABETIC NEPHROPATHY-BETA2-MICROGLOBULIN IN THE SERUM AND URINE OF TYPE-I AND TYPE-II-DIABETICS
    BRETZEL, RG
    MEYER, H
    GROSS, V
    MASER, E
    WEISE, M
    FEDERLIN, K
    MEDIZINISCHE WELT, 1985, 36 (39): : 1234 - 1237
  • [5] SIMILAR RISKS OF NEPHROPATHY IN TYPE-I AND TYPE-II DIABETES
    HASSLACHER, C
    WAHL, P
    RITZ, E
    KIDNEY INTERNATIONAL, 1988, 33 (01) : 193 - 193
  • [6] DIABETIC NEPHROPATHY - ARE THERE DIFFERENCES BETWEEN TYPE-I AND TYPE-II
    RITZ, E
    HASSLACHER, C
    TSCHOPE, W
    MINERAL AND ELECTROLYTE METABOLISM, 1990, 16 (01) : 69 - 72
  • [7] SERUM AND ERYTHROCYTE MAGNESIUM LEVELS IN TYPE-I AND TYPE-II DIABETICS
    VANROELEN, WF
    VANGAAL, LF
    VANROOY, PE
    DELEEUW, IH
    ACTA DIABETOLOGICA LATINA, 1985, 22 (03): : 185 - 190
  • [8] DEPRESSIVE SYMPTOMATOLOGY AND PERIPHERAL NEUROPATHY IN TYPE-I AND TYPE-II DIABETICS
    LEEDOM, L
    ZEIDLER, A
    MCINTYRE, R
    HOFFMAN, J
    BARON, D
    PROCCI, W
    LAUDADIO, C
    ARREZO, J
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1984, 20 (6B): : 1489 - 1489
  • [9] HETEROGENEITY OF INSULIN-RESPONSE IN RELATIVES OF TYPE-I AND TYPE-II DIABETICS
    SCHULZ, B
    RATZMANN, KP
    MICHAELIS, D
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY, 1984, 83 (03): : 327 - 333
  • [10] RELATIVE CONTRIBUTION OF TYPE-I AND TYPE-II DIABETICS TO THE CHRONIC DIALYSIS POPULATION
    GIMENEZ, L
    BRIEFEL, G
    ZACHARY, J
    WALKER, WG
    KIDNEY INTERNATIONAL, 1989, 35 (01) : 226 - 226
12345